Europe’s regulator upholds AstraZeneca's COVID-19 vaccine amid blood clot reports
April 08 2021, 08:00
A safety committee for Europe’s regulator confirmed Wednesday that the benefits for AstraZeneca’s COVID-19 vaccine continue to outweigh risks of side effects, after a review of rare and unusual blood clotting among vaccinated adults.
A safety committee for Europe’s regulator confirmed Wednesday that the benefits for AstraZeneca’s COVID-19 vaccine continue to outweigh risks of side effects, after a review of rare and unusual blood clotting among vaccinated adults.
Source:
FOX News